Northern Trust
AUPH icon

Northern Trust’s Aurinia Pharmaceuticals AUPH Stock Holding History

Northern Trust’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Buy
863,567
+39,462
+5% +$630K ﹤0.01% 1975
2026
Q1 		$12.2M Buy
824,105
+23,961
+3% +$350K ﹤0.01% 1963
2025
Q4 		$12.8M Sell
800,144
-96,303
-11% -$1.37M ﹤0.01% 1950
2025
Q3 		$9.91M Sell
896,447
-24,824
-3% -$271K ﹤0.01% 2116
2025
Q2 		$7.8M Sell
921,271
-106,212
-10% -$851K ﹤0.01% 2208
2025
Q1 		$8.26M Sell
1,027,483
-26,882
-3% -$218K ﹤0.01% 2153
2024
Q4 		$9.47M Buy
1,054,365
+58,676
+6% +$479K ﹤0.01% 2158
2024
Q3 		$7.3M Buy
995,689
+15,705
+2% +$97.4K ﹤0.01% 2251
2024
Q2 		$5.6M Sell
979,984
-42,808
-4% -$225K ﹤0.01% 2333
2024
Q1 		$5.12M Sell
1,022,792
-44,383
-4% -$301K ﹤0.01% 2437
2023
Q4 		$9.59M Buy
1,067,175
+21,794
+2% +$179K ﹤0.01% 2106
2023
Q3 		$8.12M Buy
1,045,381
+35,392
+4% +$346K ﹤0.01% 2141
2023
Q2 		$9.78M Buy
1,009,989
+24,269
+2% +$252K ﹤0.01% 2079
2023
Q1 		$10.8M Sell
985,720
-41,397
-4% -$365K ﹤0.01% 1956
2022
Q4 		$4.44M Buy
1,027,117
+22,249
+2% +$129K ﹤0.01% 2554
2022
Q3 		$7.56M Sell
1,004,868
-14,449
-1% -$125K ﹤0.01% 2185
2022
Q2 		$10.2M Buy
1,019,317
+917,113
+897% +$10.3M ﹤0.01% 2014
2022
Q1 		$1.26M Buy
102,204
+728
+0.7% +$11.3K ﹤0.01% 3316
2021
Q4 		$2.32M Buy
101,476
+4,609
+5% +$109K ﹤0.01% 3149
2021
Q3 		$2.14M Buy
+96,867
New +$1.54M ﹤0.01% 3252

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust's AUPH Position: Q2 2026 in Review

Northern Trust increased its Aurinia Pharmaceuticals (AUPH) stake by 4.8% in Q2 2026, buying an estimated $630K and bringing the position to 863,567 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

Northern Trust first reported a position in AUPH in Q3 2021 and has held it in 20 quarters since. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Northern Trust held 863,567 shares of Aurinia Pharmaceuticals worth $14.7M as of Q2 2026.
  • Northern Trust bought 39,462 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $630K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1975 holding.
  • Northern Trust first reported a position in Aurinia Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.